Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.

Tiwari AK, Brandl EJ, Weber C, Likhodi O, Zai CC, Hahn MK, Lieberman JA, Meltzer HY, Kennedy JL, Müller DJ.

J Clin Psychopharmacol. 2013 Feb;33(1):11-7. doi: 10.1097/JCP.0b013e31827d145a.

PMID:
23277265
2.

Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients.

Tiwari AK, Zai CC, Meltzer HY, Lieberman JA, Müller DJ, Kennedy JL.

Hum Psychopharmacol. 2010 Apr;25(3):253-9. doi: 10.1002/hup.1111.

PMID:
20373477
3.

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia.

Tiwari AK, Zai CC, Likhodi O, Lisker A, Singh D, Souza RP, Batra P, Zaidi SH, Chen S, Liu F, Puls I, Meltzer HY, Lieberman JA, Kennedy JL, Müller DJ.

Neuropsychopharmacology. 2010 May;35(6):1315-24. doi: 10.1038/npp.2009.235. Epub 2010 Jan 27.

4.

TNF-α -308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment.

Huang HH, Wang YC, Wu CL, Hong CJ, Bai YM, Tsai SJ, Liou YJ.

Neurosci Lett. 2011 Oct 31;504(3):277-80. doi: 10.1016/j.neulet.2011.09.046. Epub 2011 Sep 28.

PMID:
21967963
5.

Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain.

Souza RP, Tiwari AK, Chowdhury NI, Ceddia RB, Lieberman JA, Meltzer HY, Kennedy JL, Müller DJ.

J Psychiatr Res. 2012 Apr;46(4):462-8. doi: 10.1016/j.jpsychires.2012.01.010. Epub 2012 Feb 2.

PMID:
22305490
6.

A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.

Gonçalves VF, Zai CC, Tiwari AK, Brandl EJ, Derkach A, Meltzer HY, Lieberman JA, Müller DJ, Sun L, Kennedy JL.

Neuropsychopharmacology. 2014 May;39(6):1347-54. doi: 10.1038/npp.2013.312. Epub 2013 Nov 7.

7.

Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients.

Tiwari AK, Rodgers JB, Sicard M, Zai CC, Likhodi O, Freeman N, Meltzer HY, Lieberman JA, Kennedy JL, Müller DJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Dec 1;34(8):1484-90. doi: 10.1016/j.pnpbp.2010.08.009. Epub 2010 Aug 20.

PMID:
20732371
8.

Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain.

Park YM, Choi JE, Kang SG, Koo SH, Kim L, Geum D, Lee HJ.

Hum Psychopharmacol. 2011 Jun-Jul;26(4-5):332-7. doi: 10.1002/hup.1210. Epub 2011 Jun 22.

PMID:
21695734
9.

Association of the common MC4R rs17782313 polymorphism with antipsychotic-related weight gain.

Czerwensky F, Leucht S, Steimer W.

J Clin Psychopharmacol. 2013 Feb;33(1):74-9. doi: 10.1097/JCP.0b013e31827772db.

PMID:
23277235
10.

Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment.

Hong CJ, Liou YJ, Bai YM, Chen TT, Wang YC, Tsai SJ.

Pharmacogenet Genomics. 2010 Jun;20(6):359-66. doi: 10.1097/FPC.0b013e3283397d06.

PMID:
20375926
11.

Association of the alpha 2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans.

Sickert L, Müller DJ, Tiwari AK, Shaikh S, Zai C, De Souza R, De Luca V, Meltzer HY, Lieberman JA, Kennedy JL.

Pharmacogenomics. 2009 Jul;10(7):1169-76. doi: 10.2217/pgs.09.43.

PMID:
19604092
12.

Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia.

Tiwari AK, Zai CC, Likhodi O, Voineskos AN, Meltzer HY, Lieberman JA, Potkin SG, Remington G, Müller DJ, Kennedy JL.

Pharmacogenomics J. 2012 Jun;12(3):260-6. doi: 10.1038/tpj.2010.93. Epub 2011 Jan 25.

PMID:
21266946
13.

Association study of brain-derived neurotrophic factor gene polymorphisms and body weight change in schizophrenic patients under long-term atypical antipsychotic treatment.

Tsai A, Liou YJ, Hong CJ, Wu CL, Tsai SJ, Bai YM.

Neuromolecular Med. 2011 Dec;13(4):328-33. doi: 10.1007/s12017-011-8159-5. Epub 2011 Sep 29.

PMID:
21956459
14.

Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?

Le Hellard S, Theisen FM, Haberhausen M, Raeder MB, Fernø J, Gebhardt S, Hinney A, Remschmidt H, Krieg JC, Mehler-Wex C, Nöthen MM, Hebebrand J, Steen VM.

Mol Psychiatry. 2009 Mar;14(3):308-17. doi: 10.1038/sj.mp.4002133. Epub 2008 Jan 15.

PMID:
18195716
15.

Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism.

Miller DD, Ellingrod VL, Holman TL, Buckley PF, Arndt S.

Am J Med Genet B Neuropsychiatr Genet. 2005 Feb 5;133B(1):97-100.

PMID:
15635667
16.

HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.

Ma X, Maimaitirexiati T, Zhang R, Gui X, Zhang W, Xu G, Hu G.

Int J Psychiatry Clin Pract. 2014 Oct;18(4):229-42. doi: 10.3109/13651501.2014.957705. Epub 2014 Sep 18.

PMID:
25152019
17.

Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain.

Monteleone P, Milano W, Petrella C, Canestrelli B, Maj M.

J Clin Psychopharmacol. 2010 Aug;30(4):441-5. doi: 10.1097/JCP.0b013e3181e742c5.

PMID:
20631561
18.

Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.

Houston JP, Kohler J, Bishop JR, Ellingrod VL, Ostbye KM, Zhao F, Conley RR, Poole Hoffmann V, Fijal BA.

J Clin Psychiatry. 2012 Aug;73(8):1077-86. doi: 10.4088/JCP.11m06916.

PMID:
22967772
19.

Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3'-untranslated region.

Greenbaum L, Smith RC, Rigbi A, Strous R, Teltsh O, Kanyas K, Korner M, Lancet D, Ben-Asher E, Lerer B.

Pharmacogenomics J. 2009 Apr;9(2):103-10. doi: 10.1038/tpj.2008.6. Epub 2008 Mar 18.

PMID:
18347610
20.

Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain.

Kang SG, Lee HJ, Park YM, Choi JE, Han C, Kim YK, Kim SH, Lee MS, Joe SH, Jung IK, Kim L.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):160-3. Epub 2007 Aug 14.

PMID:
17804136
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk